{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:51:04Z","timestamp":1790970664264,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.ejphar.2006.12.032","type":"journal-article","created":{"date-parts":[[2007,1,22]],"date-time":"2007-01-22T16:36:10Z","timestamp":1169483770000},"page":"163-175","source":"Crossref","is-referenced-by-count":61,"title":["The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats"],"prefix":"10.1016","volume":"560","author":[{"given":"Angela B.","family":"Reksidler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo M.S.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvio M.","family":"Zanata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidevaldo B.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andreatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Tufik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.B.F.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.12.032_bib1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1471-4159.1998.71041635.x","article-title":"Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice","volume":"71","author":"Aubin","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2006.12.032_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson's disease","volume":"2","author":"Beal","year":"2001","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.ejphar.2006.12.032_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson's disease (review)","volume":"24","author":"Betarbet","year":"2002","journal-title":"BioEssays"},{"key":"10.1016\/j.ejphar.2006.12.032_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000285133","article-title":"Biological aspects of depression in Parkinson's disease","volume":"19","author":"Birkmayer","year":"1986","journal-title":"Psychopathology"},{"key":"10.1016\/j.ejphar.2006.12.032_bib5","series-title":"Experiments in Personality","first-page":"52","article-title":"Experiments in psychogenetics","author":"Broadhurst","year":"1960"},{"key":"10.1016\/j.ejphar.2006.12.032_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1353-8020(00)00042-0","article-title":"Parkinson's disease is not one disease","volume":"7","author":"Calne","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"issue":"8","key":"10.1016\/j.ejphar.2006.12.032_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"Chiba","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2006.12.032_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/neur.1996.0020","article-title":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6.tetrahydropyridine) induced Parkinson's disease mice model","volume":"5","author":"Czlonkowska","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.ejphar.2006.12.032_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2006.12.032_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0166-4328(98)00107-7","article-title":"Effects of medial and lateral caudate\u2013putamen lesions on place- and cue-guided behaviors in the water maze: relation to thigmotaxis","volume":"100","author":"Devan","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2006.12.032_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2006.06.024","article-title":"Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition (review)","volume":"545","author":"Di Filippo","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0304-3940(02)00704-8","article-title":"Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra","volume":"329","author":"Feng","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2006.12.032_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.ejphar.2006.12.032_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02260967","article-title":"MPTP-induced behavioural and biochemical deficits: a parametric analysis","volume":"7","author":"Fredriksson","year":"1994","journal-title":"J. Neural Transm., Parkinson's Dis. Dement. Sect."},{"key":"10.1016\/j.ejphar.2006.12.032_bib16","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1471-4159.1997.69031322.x","article-title":"Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter","volume":"69","author":"Gainetdinov","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2006.12.032_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0166-4328(93)90131-9","article-title":"Animal models of normal aging: relationship between cognitive decline and markers in hippocampal circuitry","volume":"57","author":"Gallagher","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2006.12.032_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0165-6147(03)00176-7","article-title":"Novel anti-inflammatory therapy for Parkinson's disease. (Review)","volume":"24","author":"Gao","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2006.12.032_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man (review)","volume":"103","author":"Gerlach","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2006.12.032_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/neur.1996.0041","article-title":"The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse","volume":"5","author":"German","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.ejphar.2006.12.032_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S1461145701002619","article-title":"L-DOPA restores striatal dopamine level but fails to reverse MPTP-induced memory deficits in rats","volume":"4","author":"Gevaerd","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","article-title":"Enzymatic oxidation of dopamine: the role of prostaglandin H synthase","volume":"64","author":"Hastings","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2006.12.032_bib23","first-page":"387","article-title":"Pathologie der Paralysis Agitants und des postenzephalitischen Parkinsonismus","volume":"48","author":"Hassler","year":"1938","journal-title":"J. Psychol. Neurol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib25","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1016\/0197-0186(92)90256-Q","article-title":"The MPTP-treated mouse as a model of parkinsonism: how good is it?","author":"Heikkila","year":"1992","journal-title":"Neurochem. Int., Suppl"},{"key":"10.1016\/j.ejphar.2006.12.032_bib24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6.tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2006.12.032_bib26","first-page":"846","article-title":"Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation","volume":"238","author":"Hess","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.12.032_bib27","first-page":"925","article-title":"Dopamine and brain function","volume":"18","author":"Hornykiewicz","year":"1966","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2006.12.032_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0006-8993(02)03164-5","article-title":"The role of cyclooxygenase 1 and 2 activity in prostaglandin E2 secretion by cultured human adult microglia: implications for Alzheimer's disease","volume":"951","author":"Hoozemans","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2006.12.032_bib29","series-title":"Statistic and Experimental Design","author":"Johnson","year":"1974"},{"key":"10.1016\/j.ejphar.2006.12.032_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/JMN:21:3:191","article-title":"Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease","volume":"21","author":"Klivenyl","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2006.12.032_bib31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.273.5280.1399","article-title":"A neostriatal habit learning system in humans","volume":"273","author":"Knowlton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2006.12.032_bib32","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1567-5769(02)00078-4","article-title":"Indomethacin protects against neurodegeneration caused by MPTP intoxication in mice","volume":"2","author":"Kurkowska-Jastrz\u0119bska","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib33","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.intimp.2004.05.006","article-title":"Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease","volume":"4","author":"Kurkowska-Jastrz\u0119bska","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.euroneuro.2004.05.007","article-title":"Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice","volume":"15","author":"Kurosaki","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine\u2013analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejphar.2006.12.032_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.05.016","article-title":"Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats","volume":"1101","author":"Lima","year":"2006","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.ejphar.2006.12.032_bib37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neubiorev.2006.03.006","article-title":"Habituation in rodents: a review of behavior, neurobiology, and genetics","volume":"30","author":"Leussis","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2006.12.032_bib38","doi-asserted-by":"crossref","first-page":"38581","DOI":"10.1074\/jbc.M005385200","article-title":"The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity","volume":"275","author":"Lotharius","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2006.12.032_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin protein reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2006.12.032_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(03)00170-0","article-title":"Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4phenyl pyridinium-induced dopaminergic neurotoxicity in rats","volume":"44","author":"Maharaj","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2006.12.032_bib41","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease","volume":"37","author":"McCoy","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2006.12.032_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tips.2004.03.003","article-title":"Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials (Review)","author":"Meissner","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2006.12.032_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0361-9230(02)00754-2","article-title":"Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced nigral lesion","volume":"58","author":"Miyoshi","year":"2002","journal-title":"Brain Res. Bull"},{"key":"10.1016\/j.ejphar.2006.12.032_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(00)02189-2","article-title":"Neuroprotecion by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"864","author":"Mohanakumar","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2006.12.032_bib68","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place Navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2006.12.032_bib45","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1073\/pnas.92.21.9697","article-title":"Spatial learning with a minislab in the dorsal hippocampus","volume":"92","author":"Moser","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2006.12.032_bib46","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.95.18.10954","article-title":"Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia","volume":"95","author":"Nakayama","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2006.12.032_bib47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0301-0082(79)90005-4","article-title":"A review of hippocampal place cells","volume":"13","author":"O\u2019Keefe","year":"1979","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1037\/0735-7044.106.3.439","article-title":"Double dissociation of fornix and caudate nucleus lesions on acquisition of two water maze tasks: further evidence for multiple memory systems","volume":"106","author":"Packard","year":"1992","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2006.12.032_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2004.03.013","article-title":"Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor","volume":"491","author":"Padi","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib50","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.ejphar.2006.12.032_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2003.11.029","article-title":"Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra in rats","volume":"484","author":"Perry","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib52","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2005.05.009","article-title":"Intra-nigral MPTP lesion in rats: behavioral and autoradiography studies","volume":"195","author":"Perry","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib53","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.10.012","article-title":"Pathogenesis of nigral cell death in Parkinson's disease. (Review)","volume":"11","author":"Przedborski","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ejphar.2006.12.032_bib54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2004.05.095","article-title":"Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse","volume":"1019","author":"Przybylkowski","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2006.12.032_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(77)90928-3","article-title":"High correlations between number of dopamine cells, dopamine levels and motor performance","volume":"134","author":"Ranje","year":"1977","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2006.12.032_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(88)90597-3","article-title":"In vivo dopaminergic neurotoxicity of the 2-beta-methylcarbolinium ion, a potential endogenous MPP+analog","volume":"153","author":"Rollema","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib56","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1046\/j.1460-9568.2000.00075.x","article-title":"Brain inflammatory reaction in animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication for Alzheimer's disease","volume":"12","author":"Scali","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2006.12.032_bib57","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1471-4159.2005.03454.x","article-title":"Post-training intrahippocampal infusion of nicotine prevents spatial memory retention deficits induced by the cyclo-oxygenase-2-specific inhibitor celecoxib in rats","volume":"95","author":"Sharifzadeh","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2006.12.032_bib58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2006.12.032_bib59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(86)90444-9","article-title":"The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice","volume":"129","author":"Sonsalla","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0892-0362(02)00222-2","article-title":"MPTP: insights into parkinsonian neurodegeneration. (Review)","volume":"24","author":"Speciale","year":"2002","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib61","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease","volume":"16","author":"Sriram","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2006.12.032_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-8993(87)90986-3","article-title":"Studies on the effect of 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL\/6 mice. Comparison with three other strains of mice","volume":"405","author":"Sundstr\u00f6m","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2006.12.032_bib69","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0361-9230(97)00452-8","article-title":"Cognitive changes in mice following moderate MPTP exposure","volume":"45","author":"Tanila","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2006.12.032_bib63","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2006.12.032_bib64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2006.12.032_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000136753","article-title":"Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain?","volume":"16","author":"Tufik","year":"1978","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2006.12.032_bib66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-7091-6846-2_15","article-title":"Treatment of behavioural disturbances in Parkinson's disease","volume":"51","author":"Valldeoriola","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2006.12.032_bib67","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T22:59:27Z","timestamp":1628377167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":70,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0014299907000532"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.12.032","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}